Amalia Diakidou

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Pharmathen S.a., Expermed S.a.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amalia Diakidou. Retrieved from https://idiyas.com/inventor/amalia-diakidou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 8.2

ph-index = 1

Company Filing History:

Years Active: 2017-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458645 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-11-04),

2. 12453732 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-10-28),

3. 11969429 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2024-04-30),

4. 11318114 - Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof (2022-05-03),

5. 11154585 - Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population (2021-10-26),

6. 9675551 - Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof (2017-06-13),

7. 9561186 - Method for improving the bioavailability of low aqueous solubility drugs (2017-02-07),

Title: Amalia Diakidou: Innovator in Pediatric Pharmaceutical Solutions

Introduction

Amalia Diakidou is a prominent inventor based in Pallini Attikis, Greece. She has made significant contributions to the field of pharmaceuticals, particularly in developing innovative solutions for pediatric care. With a total of seven patents to her name, her work focuses on enhancing the efficacy and safety of antiviral medications for children.

Latest Patents

One of her latest patents is a pediatric powder for oral suspension containing an antiviral agent and a method for its preparation. This innovative powder includes Valaciclovir or its pharmaceutical acceptable salts or derivatives, combined with an ion exchange resin to form Drug-Resin complex (DRC) particles. Each DRC particle is characterized by hydrogen bonds between the ion exchange resin and a cationic center of Valaciclovir. The specific ratio of Valaciclovir to the ion exchange resin in the DRC particle is 1:0.5. Additionally, the powder contains a suspending agent and a pH agent, which helps to form a film around each DRC particle, reducing interparticle attraction. This formulation is designed to be reconstituted with an aqueous diluent for oral administration, making it suitable for pediatric patients.

Career Highlights

Throughout her career, Amalia has worked with notable companies in the pharmaceutical industry, including Pharmathen S.A. and Expermed S.A. Her experience in these organizations has allowed her to develop and refine her innovative approaches to pediatric pharmaceuticals.

Collaborations

Amalia has collaborated with several professionals in her field, including Evangelos Karavas and Vasiliki Samara. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Amalia Diakidou stands out as a dedicated inventor in the pharmaceutical industry, particularly in the development of pediatric antiviral solutions. Her innovative patents and collaborative efforts continue to make a significant impact on children's healthcare.

Profile summary based on public USPTO records.